Cargando…
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
Natural infection with SARS-CoV-2 induces a robust circulating memory B cell (Bmem) population, which remains stable in number at least 8 months post-infection despite the contraction of antibody levels after 1 month. Multiple vaccines have been developed to combat the virus. These include two new f...
Autores principales: | Fryer, Holly A., Hartley, Gemma E., Edwards, Emily S.J., O'Hehir, Robyn E., van Zelm, Menno C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788580/ https://www.ncbi.nlm.nih.gov/pubmed/36421662 http://dx.doi.org/10.1042/BST20220415 |
Ejemplares similares
-
New insights into human immune memory from SARS‐CoV‐2 infection and vaccination
por: Hartley, Gemma E., et al.
Publicado: (2022) -
COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
por: Fryer, Holly A., et al.
Publicado: (2023) -
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
por: Hartley, Gemma E., et al.
Publicado: (2020) -
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2
por: Hartley, Gemma E., et al.
Publicado: (2022) -
Influenza‐specific IgG1(+) memory B‐cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency
por: Hartley, Gemma E, et al.
Publicado: (2020)